Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice.
Hua L, Fang M, Dong B, Guo S, Cui C, Liu J, Yao Y, Xiao Y, Li X, Ren Y, Meng X, Hao X, Zhao P, Song Y, Wang L, Yu Y.
Hua L, et al. Among authors: xiao y.
Oncotarget. 2016 Dec 13;7(50):82369-82383. doi: 10.18632/oncotarget.10693.
Oncotarget. 2016.
PMID: 27448968
Free PMC article.